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THE RELATIVE BIOLOGICAL EFFECTIVENESS OF 
160 MeV PROTONS—Ilt 
BIOLOGICAL DATA AND THEIR INTERPRETATION IN TERMS 
OF MICRODOSIMETRY 
ERIC J . H A L L , D.Phil., A L B R E C H T M . K E L L E R E R , Ph.D.,t H A R A L D H . ROSSI, 
Ph.D. and Y U K - M I N G P. L A M , Ph.D. 
Radiological Research Laboratory, College of Physicians and Surgeons, Columbia University, New York, 
N Y 10032, U.S.A. 
The radiobiological effectiveness of 160 MeV protons was measured relative to M Co y-rays, using Chinese 
hamster cells cultured i n v i t r o . Separate experiments were performed with cells irradiated in S u s p e n s i o n , or 
attached to plastic tissue culture flasks. Proton irradiations were performed in the incident plateau of the depth 
dose profile and with the Bragg peak spread out to cover 10 cm. In all cases the relative biological effectiveness 
(RBE) for protons relative to gamma rays was 1.2 for doses in excess of about 200 rad. The attached cell 
experiments indicate an increasing RBE at low doses, which is consistent with the microdosimetric measure-
ments. 
Protons, Bragg peak, Microdosimetry, Relative biological effectiveness. 
INTRODUCTION 
The dose deposited by a proton beam increases with 
depth in the exposed medium and reaches a sharp 
maximum in the region of the Bragg peak, close to 
the end of the particles' ränge. Beyond the particles' 
ränge, the dose becomes very small. By using a 
proton beam of suitable energy (and therefore ränge), 
a tumor volume located at any depth in the body can, 
in principle, be irradiated preciseiy and selectively to 
a high dose, with a minimal dose to the intervening 
normal tissues and a negligible dose to the deeper 
tissues. This attractive feature of heavy charged 
particles, and its potential application to radiotherapy, 
was recognized early by Wilson. 9 
Much of the early clinical use of protons involved 
pencil beams to treat the pituitary gland, first at the 
184 in. Berkeley cyclotron, and later at the Harvard 
cyclotron. The Harvard cyclotron has an energy of 
160 M e V , which means that the unmodified beam 
would have a sharp Bragg peak at a depth of about 
18 cm in unit density material. The sharp Bragg peak 
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Nos. CA-12536, CA-18506 awarded by the National Cancer 
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Acknowledgements—This investigation was conducted at 
associated with monoenergetic protons is of little use 
in broad beam radiotherapy. However, the Bragg 
peak can be spread out to cover any hypothetical 
tumor dimension, certainly up to 10 cm, by the use of 
a moving absorber of variable thickness. 6 
In preparation for a clinical trial of proton radiation 
therapy, the Harvard group invited a number of 
outside investigators to make measurements of the 
relative biological effectiveness (RBE) of protons 
compared with ^ C o y-rays. The radiobiological 
experiments described in the present paper were the 
result of this invitation, and the microdosimetric 
studies which followed were motivated by the need 
to understand the results that were obtained. 
Robertson et a\? had performed prior radiobio-
logical studies with the Harvard proton beam, using 
cells in culture, an R B E close to unity was reported. 
In the literature, there is a wide spread in R B E data 
for various proton beams in a multitude of biological 
Systems, but few relevant to the broad beam radio-
therapy Situation. 
the S u g g e s t i o n of Dr. Herman Suit. We are indebted to Dr. 
Michael Goitein and Dr. Andy Koehler for arranging beam 
time on the Harvard Cyclotron, and for simultaneous ir-
radiation facilities on the ^Co teletherapy unit at the 
Massachusetts General Hospital. 
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METHODS AND MATERIALS 
V79 Chinese hamster cells were used for the 
biological intercomparisons, cultured according to 
Standard techniques, and grown in F10 culture 
medium (Grand Island Biological Company), 
supplemented with 10% fetal calf serum and antibio-
tics. Two series of experiments were performed, one 
with cells irradiated while attached to Falcon plastic 
tissue culture dishes, and one with cells irradiated in 
Suspension. 
For the attached cell experiments, cells were 
harvested by trypsinization, counted in a Coulter 
electronic counter and appropriate numbers seeded 
into small (25 cm 2) Falcon tissue culture flasks in 
10 ml of medium. After overnight attachment at 37°C, 
the flasks were removed from the incubator, filled 
brimful with tissue culture medium and maintained at 
17°C for the trip to Boston. Plates were randomized 
into two groups and irradiated with graded doses of 
protons at the Harvard cyclotron or with ^ C o y-rays 
at the Massachusetts General Hospital. Six replicates 
were used for each dose level, and each type of 
radiation. Following irradiation, the flasks were 
transported back to Columbia University, N e w Y o r k 
and incubated at 37.5°C for 8 days to allow colony 
formation, after this, the cells were fixed and stained, 
and the number of colonies per flask counted by a 
projection technique. 
For experiments involving cells in Suspension, cells 
were harvested by trypsinization from a partly 
confluent, actively growing stock flask, and prepared 
into a Suspension in complete growth medium. After 
counting in a Coulter electronic counter, suspensions 
were prepared containing various concentrations of 
cells from 600 to 3 x 104 cells/ml. Series of small 
plastic vials were filled, each with one-third of a 
milliliter of these various cell suspensions. These 
vials, fabricated from Falcon plastic disposable 1 ml 
pipets, were 6 cm long, with inside and outside 
diameters of 2 and 4 mm respectively. The ends were 
sealed by the application of heat. It has been found 
that cells may be stored in this way at a temperature 
of about 17°C for periods of at least 24 hr without loss 
of plating efficiency (which characteristically is 
greater than 80%) and without any change in the age 
distribution of cells within the mitotic cycle. This has 
been described in previous publications. 1 , 2 
The vials were prepared and filled with cells in 
New York , and transported to Boston where half 
were irradiated with protons and half with ^ C o 
gamma rays at the Massachusetts General Hospital . 
Vials containing appropriate numbers of cells were 
irradiated with graded doses; eight replicates were 
used for each dose level and type of radiation. After 
irradiation, the vials were transported back to New 
York and agitated vigorously on a vortex mixer to 
resuspend the cells, before they were opened and the 
contents of each vial transferred to a Falcon culture 
flask containing fresh growth medium. After 8 days 
incubation at 37°C, the cells were fixed and stained; 
the number of macroscopic colonies per flask were 
counted by a projection technique. The cells were in 
the vials for a total of 12 hr including transportation 
and irradiation; and during this time they were kept at 
about 17°C in an insulated carrier. 
D o s i m e t r y 
Dosimetry was provided by the Harvard group (Dr. 
Michael Goitein and Dr. Andy Koehler) as it was 
used for the clinical applications of the protons and 
^ C o y-rays. In the case of the y-rays, absorbed dose 
was computed from measurements with a Farmer 
0.6 cm 3 ionization Chamber, using a calibration factor 
determined by comparison with a Farmer Chamber 
calibrated by the National Bureau of Standards. The 
dose delivered by protons was determined from 
measurements with a 0 .1cm 3 ionization Chamber 
which had been intercalibrated against a Faraday cup 
in a monoenergetic proton beam. 
RESULTS AND DATA ANALYSIS 
Two visits were made to Boston. On each occasion 
separate experiments were performed with attached 
cells and cells in Suspension. 
On the first occasion, survival curves were 
obtained for cells irradiated at the center of the 
spread-out Bragg peak (position A in Fig . 1), and 
compared with ^ C o y-rays. On the second occasion, 
cells were irradiated again at the center of the spread-
out Bragg peak, but also in the plateau (position B in 
Fig. 1). Survival curves also were obtained for ^ C o 
y-rays. Figure 2 shows the data for attached cells in 
the first and second experiment. The data points are 
plotted, together with their Standard deviations. 
These data were analyzed in two different ways. 
A 
I I i I ' I ' I i I ' l i i I i I ' ! i I I 
loo- — — . — ^ 
80 Spread Out Brogg Peak j * 
«x 4 0 - B ^ 
- J± ~" 
20-
QI I i I i I i I i I t I i I i I i I 1 I 
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DISTANCE FROM BRAGG PEAK (cm) 
Fig. 1. Depth dose profiles for 160 MeV protons at the 
Harvard cyclotron. Curve A—Spread out Bragg peak. A 
moving absorber of variable thickness is used to spread out 
the Bragg peak to cover 10 cm. Curve B—Unmodified beam 
with a sharp Bragg peak at a depth of about 16 cm. 
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A T T A C H E D C E L L S 
First Experiment Second Experiment 
—I 1 1 1 
Fig. 2. Survival data for V79 Chinese hamster cells, ir-
radiated attached to Falcon tissue culture flasks and ir-
radiated with ^Co y-rays or with protons in the spread-out 
Bragg peak (SOBP) or plateau positions of the depth dose 
profile. (Positions A and B respectively in Fig. 1). Two 
separate experiments were performed separated by several 
months. The curves were fitted to the data by a method 
described in the text. 
One of these employs the non-parametric method 
developed by Kellerer and Brenot 3 which permits the 
construction of an envelope of the R B E vs absorbed 
dose curve. The results are shown in Fig . 3(a-c). 
There is a strong indication that the proton R B E 
exceeds unity at all dose levels and that it increases at 
doses below a few hundred rad. 
In addition, the data were fitted by a new method 
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Fig. 3. Proton R B E as a function of proton dose computed 
by the non-parametric analysis of Kellerer and Brenot.3 The 
analysis was carried out on the data in Fig. 2. Panel (a) 
refers to data obtained in the spread-out Bragg peak posi-
tion in the first experiment. Panels (b) and (c) refer to data 
obtained in the plateau and spread-out Bragg peak in the 
second experiment. The vertical bars denote R B E values 
which are excluded at a confidence level of 95%, while the 
detached arrows indicate values that are unlikely at a lower 
level of confidence. The most likely R B E values fall in the 
Space between the vertical bars. There is strong evidence 
that the proton R B E exceeds unity at all dose levels, and 
that it increases at doses below a few hundred rad. 
for the dose-effect relationship. A l l that is assumed is 
that the curve is convex upwards, which assures a 
smooth fit. The three proton curves, one obtained at 
the first visit, and two at the second, were fitted with 
a curve of the same shape. A Computer program 
searches for that convex curve which fits the three 
100 curves best. A simultaneous fit is made possible by 
allowing different dose modifying factors for the in-
dividual curves. Different vertical shifts are also 
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permitted for the two experiments to account for the 
possibility that the unirradiated controls are not 
necessarily the "correct" values; however, this effect 
is negligibly small since large numbers of control 
colonies were counted. Curves of the same shape (but 
different from the proton data) also were fitted to the 
survival data for the ^ C o y-ray irradiations for the 
two experiments. The results of this Atting procedure 
are shown by the curves in Fig. 2. Based on these 
best-fit curves, the R B E of protons, compared with 
^ C o y-rays, can be computed as a function of dose 
for the attached cells; Fig. 4 shows the results. The 
R B E for protons is about 1.2 at high doses, but 
increases at low doses. There is only a small 
difference between the biological effectiveness of 
protons in the spread-out Bragg peak, compared with 
the plateau, the peak has a slightly greater effective-
ness. 
Figure 5 shows data for cells irradiated in Suspen-
sion. The same method of curve Atting is applied as in 
the case of the attached cells. The data are subject to 
greater fluctuations than the attached cell data, and in 
particular, the y-ray curves are rather ill-defined. 
Consequently, these data do not Warrant an explicit 
analysis of R B E as a function of dose; however, they 
certainly support the conciusion that the R B E 
difference between plateau and extended peak pro-
tons is probably not significant, and that in both 
cases, the charged particle beam is more effective 
than ^ C o y-rays by about 20%. 
C E L L S I N S U S P E N S I O N 
First Experiment Second Experiment 
DOSE (Gy) 
Fig. 5. Survival data for V79 Chinese hamster cells ir-
radiated in Suspension with ^Co y-rays or with protons in 
the spread-out Bragg peak (SOBP) or plateau positions of 
the depth dose profile (positions A or B respectively in Fig. 
1). Two separate experiments were performed on different 
occasions. The curves were fitted to the data by a method 
described in the text. 
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DISCUSSION 
According to the theory of dual radiation action, 4 
the rate of production of radiation induced lesions is 
given by: 
E ( D ) = k(£D + D 2 ) . . . (1) 
where £ is the quotient of the second and first mo-
ments of the specific energy deposited by single 
events, D is the absorbed dose, and k is a constant 
that is related to the effectiveness with which in-
dividual charged particles produce the sublesions that 
combine in pairs to form lesions. 
According to eqn (1), the R B E at large doses 
should be equal to the ratio of the values Vfc for the 
radiations under comparison. Although in an initial 
approximation k was considered to be independent of 
radiation quality, it was pointed out 4 that a depen-
dence was likely to exist, and that it probably resulted 
from differences of energy deposition at the 
nanometer level. 8 In the present study the R B E of 
protons relative to ^ C o y-rays is close to 1.2 at high 
doses. The value is similar to that observed for 
orthovoltage X-rays compared with y-rays. This is 
consistent with the fact that both protons and y-rays 
have dose lineal energies that are similar to one 
another, and significantly higher than the comparable 
figure for ^ C o y-rays. 
At doses that are comparable to, or less than, £ for 
protons, the R B E must increase as the dose decreases 
in a manner indicated by eqn (1). At very low doses, 
that are significantly smaller than the ( for either type 
of radiation, the R B E reaches a limiting value equal 
to kp£plkyi;y where the subscripts p and y refer to 
protons and y-rays. Although values of £ depend on 
the diameter of the site (i.e. the effective volume over 
which sublesions combine), their ratio is largely in-
dependent of site diameter and equal to the ratio of 
lineal energies. Values of y*, the dose average lineal 
energy, corrected for Saturation, were reported in 
Kilauga et a l . 5 The quantity is proportional to £; 
therefore, it may be substituted in the calculation of 
ratios. One obtains ratios of £'s for protons and 
y-rays that are about 5.7/1.9 = 3 at the center of the 
spread-out Bragg peak and 4.8/1.9 = 2.5 at the pla-
teau. If v / k p l k y is taken as 1.2, the maximum R B E 
predicted is near 4.3 for the spread-out peak and 
about 3.6 for the plateau. 
The data for attached cells in Figs. 2-4 show the 
rise of R B E with decreasing dose expected from the 
microdosimetric considerations outlined above. The 
limiting values are not reached because of the prac-
tica! difficulties involved in obtaining biological data 
of sufficient Statistical accuracy at doses below 
100 rad. The data for suspended cells (Fig. 5) show 
little or no rise of R B E . However, an increase of 
R B E at lower doses cannot be ruled out. Such a 
displacement to lower doses conceivably could reflect 
a larger site diameter for suspended cells because of 
their different physiological State. 
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